−0.53CNY
−65.78 MCNY
139.97 MCNY
92.55 M
About JIANGSU GDK BIOTECHNOLOGY
Sector
Industry
CEO
Jian Hui Zhang
Website
Headquarters
Taizhou
Founded
2008
ISIN
CNE100004NR4
FIGI
BBG00Y009ZC4
Jiangsu gdk Biotechnology Co., Ltd. engages in the research and development, production and sale of human vaccines. Its products include freeze-dried human rabies, quadrivalent influenza virus, 23-valent pneumococcal polysaccharide, freeze-dried live attenuated varicella, freeze-dried live attenuated herpes zoster, 13-valent pneumococcal polysaccharide conjugate and recombinant shingles vaccines. The company was founded by Yun De Hou and Jing Zhao on December 29, 2008 and is headquartered in Taizhou, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 688670 is 16.47 CNY — it has decreased by 5.72% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange JIANGSU GDK BIOTECHNOLOGY stocks are traded under the ticker 688670.
JIANGSU GDK BIOTECHNOLOGY is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track JIANGSU GDK BIOTECHNOLOGY financials in yearly and quarterly reports right on TradingView.
Like other stocks, 688670 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JIANGSU GDK BIOTECHNOLOGY stock right from TradingView charts — choose your broker and connect to your account.